TUCSON   520.748.4400

APT Pharmaceuticals

APT Pharmaceuticals, Inc. was founded to develop inhaled therapeutics for inflammatory diseases and transplantation. The company’s lead program was inhaled cyclosporine which it developed through a pivotal Phase III clinical trial.